EP
ZBH icon

Eudaimonia Partners’s Zimmer Biomet ZBH Stock Holding History

Eudaimonia Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-222
Closed -$35K – 1402
2021
Q1 		$35K Hold
222
– – 0.01% 758
2020
Q4 		$33K Hold
222
– – 0.01% 733
2020
Q3 		$29K Hold
222
– – 0.01% 704
2020
Q2 		$26K Hold
222
– – 0.01% 663
2020
Q1 		$22K Hold
222
– – 0.01% 642
2019
Q4 		$32K Buy
+222
New +$30.6K 0.01% 591

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Eudaimonia Partners's ZBH Position: Q2 2021 in Review

Eudaimonia Partners sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 222 shares — an estimated $35K sold.

Eudaimonia Partners first reported a position in ZBH in Q4 2019 and held it in 6 quarters. The position peaked at $35K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

  • Eudaimonia Partners reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 222 Zimmer Biomet shares in Q2 2021, an estimated $35K.
  • Eudaimonia Partners first reported a position in Zimmer Biomet in Q4 2019 and held it in 6 quarters.
  • Eudaimonia Partners's Zimmer Biomet position peaked at $35K in Q1 2021.
  • 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.